On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Brain imaging plays an increasingly important role in experimental medicine for dementia by providing biomarkers for diagnosis, prognosis, patient stratification and monitoring treatment response. Imaging can also provide insights into mechanisms of risk and resilience for neurodegeneration. The Translational Neuroimaging Group investigate brain ageing in both health and disease. We have demonstrated that people at increased risk of later developing Alzheimer’s and Parkinson’s disease have particular ‘signatures’ of brain activity. I will introduce some of the methodology and describe how the techniques are being used to improve our understanding of brain ageing.
